Geraldo Felício Cunha-Junior1,2, Luciana Bastos-Rodrigues3,4, Pedro G Azevedo4, Maria Aparecida Bicalho1,4, Luiz Alexandre V Magno4, Luiz De Marco5,6, Luiz Gonzaga Coelho1. 1. Department of Internal Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. 2. Department of Oncology, Hospital da Baleia, Fundação Benjamim Guimarães, Belo Horizonte, Brazil. 3. Department of Nutrition, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. 4. Molecular Medicine Technology Center, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. 5. Department of Surgery, Federal University of Minas Gerais, Av. Professor Alfredo Balena 190, Belo Horizonte, 30130-100, Brazil. Ldemarco@ufmg.br. 6. Molecular Medicine Technology Center, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Ldemarco@ufmg.br.
Abstract
PURPOSE: The presence of deleterious variants of dihydropyrimidine-dehydrogenase gene (DPYD) is associated with 5-Fluorouracil toxicity. Most of the data are based on findings in Caucasian populations. The variant Y186C (rs115232898) is found almost exclusively in African populations and is related to low DPD function. Its prevalence may vary among African subpopulations and in African Americans. There is no information in other populations. Brazil has the biggest African population outside Africa. We studied for the first time the frequency of this mutation in African Brazilians. METHODS: We amplified exon 6 of DPYD extracted from genomic DNA of 79 healthy volunteers of genetically defined African ancestry from Southeast Brazil and 36 self-reported African descendants from Northeast Brazil in order to determine the prevalence of the variant Y186C in Brazilians of African ancestry. RESULTS: The variant Y186C was found in heterozygosity in two samples from Southeast (2.53%) and one from Northeast (2.77%) Brazil. Overall, the prevalence of this mutation in the 115 African Brazilians was 2.6%. CONCLUSIONS: The variant Y186C is prevalent among Brazilians of African ancestry and should be taken in account in targeted genotyping for fluoropyrimidine risk variants.
PURPOSE: The presence of deleterious variants of dihydropyrimidine-dehydrogenase gene (DPYD) is associated with 5-Fluorouraciltoxicity. Most of the data are based on findings in Caucasian populations. The variant Y186C (rs115232898) is found almost exclusively in African populations and is related to low DPD function. Its prevalence may vary among African subpopulations and in African Americans. There is no information in other populations. Brazil has the biggest African population outside Africa. We studied for the first time the frequency of this mutation in African Brazilians. METHODS: We amplified exon 6 of DPYD extracted from genomic DNA of 79 healthy volunteers of genetically defined African ancestry from Southeast Brazil and 36 self-reported African descendants from Northeast Brazil in order to determine the prevalence of the variant Y186C in Brazilians of African ancestry. RESULTS: The variant Y186C was found in heterozygosity in two samples from Southeast (2.53%) and one from Northeast (2.77%) Brazil. Overall, the prevalence of this mutation in the 115 African Brazilians was 2.6%. CONCLUSIONS: The variant Y186C is prevalent among Brazilians of African ancestry and should be taken in account in targeted genotyping for fluoropyrimidine risk variants.